Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	LRR_8	ASPN LRRK2 LRRC10 OMD LRRN3 CNOT6L FLRT3 FLRT1	7.26e-06	171	109	8	PF13855
Domain	Leu-rich_rpt_typical-subtyp	ASPN LRRK2 LRRC10 OMD LRRN3 CNOT6L FLRT3 FLRT1	9.35e-06	177	109	8	IPR003591
Domain	LRR_TYP	ASPN LRRK2 LRRC10 OMD LRRN3 CNOT6L FLRT3 FLRT1	9.35e-06	177	109	8	SM00369
Domain	LRRNT	ASPN OMD LRRN3 FLRT3 FLRT1	1.42e-05	53	109	5	PF01462
Domain	LRR	ASPN LRRK2 LRRC10 OMD LRRN3 CNOT6L FLRT3 FLRT1	2.35e-05	201	109	8	PS51450
Domain	Clathrin_H-chain_propeller_rpt	CLTCL1 CLTC	3.37e-05	2	109	2	IPR022365
Domain	Clathrin-link	CLTCL1 CLTC	3.37e-05	2	109	2	PF09268
Domain	-	CLTCL1 CLTC	3.37e-05	2	109	2	2.130.10.110
Domain	Clathrin_H-chain_link/propller	CLTCL1 CLTC	3.37e-05	2	109	2	IPR016025
Domain	Clathrin_propel	CLTCL1 CLTC	3.37e-05	2	109	2	PF01394
Domain	Clathrin_heavy_chain	CLTCL1 CLTC	3.37e-05	2	109	2	IPR016341
Domain	Clathrin_H-chain_linker_core	CLTCL1 CLTC	3.37e-05	2	109	2	IPR015348
Domain	Clathrin_H-chain_propeller_N	CLTCL1 CLTC	3.37e-05	2	109	2	IPR001473
Domain	LRR_1	ASPN LRRK2 LRRC10 OMD LRRN3 CNOT6L FLRT3 FLRT1	4.33e-05	219	109	8	PF00560
Domain	Clathrin_H-chain_linker	CLTCL1 CLTC	1.01e-04	3	109	2	IPR012331
Domain	CLH	CLTCL1 CLTC	1.01e-04	3	109	2	SM00299
Domain	Leu-rich_rpt	ASPN LRRK2 LRRC10 OMD LRRN3 CNOT6L FLRT3 FLRT1	1.90e-04	271	109	8	IPR001611
Domain	LRRNT	ASPN OMD LRRN3 FLRT3 FLRT1	2.72e-04	98	109	5	IPR000372
Domain	LRRNT	ASPN OMD LRRN3 FLRT3 FLRT1	2.72e-04	98	109	5	SM00013
Domain	-	ASPN LRRK2 LRRC10 OMD LRRN3 CNOT6L FLRT3 FLRT1	5.89e-04	321	109	8	3.80.10.10
Domain	L_dom-like	ASPN LRRK2 LRRC10 OMD LRRN3 CNOT6L FLRT3 FLRT1	6.79e-04	328	109	8	IPR032675
Domain	Clathrin	CLTCL1 CLTC	6.95e-04	7	109	2	PF00637
Domain	CHCR	CLTCL1 CLTC	6.95e-04	7	109	2	PS50236
Domain	Clathrin_H-chain/VPS_repeat	CLTCL1 CLTC	9.24e-04	8	109	2	IPR000547
Domain	Interfer-bind	IFNGR2 IL22RA2	1.47e-03	10	109	2	PF09294
Domain	Interferon/interleukin_rcp_dom	IFNGR2 IL22RA2	1.47e-03	10	109	2	IPR015373
Domain	Tissue_fac	IFNGR2 IL22RA2	2.14e-03	12	109	2	PF01108
Domain	Tissue_factor	IFNGR2 IL22RA2	2.14e-03	12	109	2	IPR001187
Domain	Dynein_heavy_chain_D4_dom	DNAH10 DNAH7	2.93e-03	14	109	2	IPR024317
Domain	Dynein_HC_stalk	DNAH10 DNAH7	2.93e-03	14	109	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH10 DNAH7	2.93e-03	14	109	2	IPR013602
Domain	DHC_N2	DNAH10 DNAH7	2.93e-03	14	109	2	PF08393
Domain	MT	DNAH10 DNAH7	2.93e-03	14	109	2	PF12777
Domain	AAA_8	DNAH10 DNAH7	2.93e-03	14	109	2	PF12780
Domain	uDENN	DENND1B DENND2C	2.93e-03	14	109	2	SM00800
Domain	DHC_fam	DNAH10 DNAH7	3.37e-03	15	109	2	IPR026983
Domain	Dynein_heavy_dom	DNAH10 DNAH7	3.37e-03	15	109	2	IPR004273
Domain	uDENN	DENND1B DENND2C	3.37e-03	15	109	2	PF03456
Domain	Dynein_heavy	DNAH10 DNAH7	3.37e-03	15	109	2	PF03028
Domain	UDENN	DENND1B DENND2C	3.84e-03	16	109	2	PS50946
Domain	DDENN	DENND1B DENND2C	3.84e-03	16	109	2	PS50947
Domain	DENN	DENND1B DENND2C	3.84e-03	16	109	2	SM00799
Domain	dDENN	DENND1B DENND2C	3.84e-03	16	109	2	SM00801
Domain	DENN	DENND1B DENND2C	3.84e-03	16	109	2	PF02141
Domain	dDENN_dom	DENND1B DENND2C	3.84e-03	16	109	2	IPR005112
Domain	uDENN_dom	DENND1B DENND2C	3.84e-03	16	109	2	IPR005113
Domain	dDENN	DENND1B DENND2C	3.84e-03	16	109	2	PF03455
Domain	DENN	DENND1B DENND2C	3.84e-03	16	109	2	PS50211
Domain	DENN_dom	DENND1B DENND2C	3.84e-03	16	109	2	IPR001194
Domain	AT_hook	PRR12 KMT2A	3.84e-03	16	109	2	PF02178
Pubmed	The cooperative function of nuclear receptor coactivator 1 (NCOA1) and NCOA3 in placental development and embryo survival.	PDPK2P PPARD MAPK3 ERVFRD-1	1.66e-06	26	116	4	20685850
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TET2 MCMBP SORBS1 STIL DNAH7 NHSL1 DENND1B SIPA1L1 DOCK7 KMT2A TAB1 DNMBP YTHDF2	6.32e-06	861	116	13	36931259
Pubmed	The downregulation of BAP1 expression by BCR-ABL reduces the stability of BRCA1 in chronic myeloid leukemia.	BAP1 BRCA1	1.10e-05	2	116	2	26118501
Pubmed	PILRα and PILRβ have a siglec fold and provide the basis of binding to sialic acid.	PILRB PILRA	1.10e-05	2	116	2	24843130
Pubmed	BAP1 loss induces mitotic defects in mesothelioma cells through BRCA1-dependent and independent mechanisms.	BAP1 BRCA1	1.10e-05	2	116	2	36550359
Pubmed	New candidate SNPs for genetic association with Alzheimer's disease: a linkage disequilibrium analysis for the FCGRIIB and PILRA genes.	PILRA FCGR2A	1.10e-05	2	116	2	38408113
Pubmed	Human microcephaly protein RTTN interacts with STIL and is required to build full-length centrioles.	RTTN STIL	1.10e-05	2	116	2	28811500
Pubmed	A single-amino-acid substitution in herpes simplex virus 1 envelope glycoprotein B at a site required for binding to the paired immunoglobulin-like type 2 receptor alpha (PILRalpha) abrogates PILRalpha-dependent viral entry and reduces pathogenesis.	PILRB PILRA	1.10e-05	2	116	2	20686018
Pubmed	Characterization of a second human clathrin heavy chain polypeptide gene (CLH-22) from chromosome 22q11.	CLTCL1 CLTC	1.10e-05	2	116	2	8733129
Pubmed	Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors.	LRRK2 BAP1	1.10e-05	2	116	2	34008015
Pubmed	CHC22 and CHC17 clathrins have distinct biochemical properties and display differential regulation and function.	CLTCL1 CLTC	1.10e-05	2	116	2	29097553
Pubmed	Deubiquitinase BAP1 regulates stability of BRCA1 protein and inactivates the NF-κB signaling to protect mice from sepsis-induced acute kidney injury.	BAP1 BRCA1	1.10e-05	2	116	2	37414201
Pubmed	Neutrophil infiltration during inflammation is regulated by PILRα via modulation of integrin activation.	PILRB PILRA	1.10e-05	2	116	2	23142774
Pubmed	Mutual regulation between GDF11 and TET2 prevents senescence of mesenchymal stem cells.	TET2 GDF11	1.10e-05	2	116	2	37801347
Pubmed	Modulation of paired immunoglobulin-like type 2 receptor signaling alters the host response to Staphylococcus aureus-induced pneumonia.	PILRB PILRA	1.10e-05	2	116	2	20065029
Pubmed	The clathrin heavy chain isoform CHC22 functions in a novel endosomal sorting step.	CLTCL1 CLTC	1.10e-05	2	116	2	20065094
Pubmed	BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.	BAP1 BRCA1	1.10e-05	2	116	2	9528852
Pubmed	Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder.	BAP1 BRCA1	1.10e-05	2	116	2	35051358
Pubmed	PILRα negatively regulates mouse inflammatory arthritis.	PILRB PILRA	1.10e-05	2	116	2	24935926
Pubmed	The Ig-like v-type domain of paired Ig-like type 2 receptor alpha is critical for herpes simplex virus type 1-mediated membrane fusion.	PILRB PILRA	1.10e-05	2	116	2	20573830
Pubmed	Monocyte infiltration into obese and fibrilized tissues is regulated by PILRα.	PILRB PILRA	1.10e-05	2	116	2	26840635
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TET2 DIDO1 PLXND1 BAP1 TRMT6 ATP11B HMGXB3 FLRT3 DNA2 DNMBP	1.18e-05	529	116	10	14621295
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	CLTCL1 RTTN SPATA20 PLXND1 ARHGAP35 SPPL2B BAP1 PRR12 NHSL1 SLC12A4 ZFYVE26 HMGXB3 DNMBP SYMPK	1.96e-05	1105	116	14	35748872
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	MIS18BP1 SORBS1 STIL LCP1 LRP1B DNAH7 UBR5 SIPA1L1 TAB1 DNMBP PCBP2 YTHDF2	2.93e-05	853	116	12	28718761
Pubmed	Blood flow guides sequential support of neutrophil arrest and diapedesis by PILR-β1 and PILR-α.	PILRB PILRA	3.30e-05	3	116	2	31385804
Pubmed	The CD8α-PILRα interaction maintains CD8+ T cell quiescence.	PILRB PILRA	3.30e-05	3	116	2	35617401
Pubmed	Functional equivalence of the clathrin heavy chains CHC17 and CHC22 in endocytosis and mitosis.	CLTCL1 CLTC	3.30e-05	3	116	2	19509056
Pubmed	Altered ERK/MAPK signaling in the hippocampus of the mrsk2_KO mouse model of Coffin-Lowry syndrome.	RPS6KA3 MAPK3	3.30e-05	3	116	2	21838783
Pubmed	Identification of FLRT1, FLRT2, and FLRT3: a novel family of transmembrane leucine-rich repeat proteins.	FLRT3 FLRT1	3.30e-05	3	116	2	10644439
Pubmed	Negative regulation of DSS-induced experimental colitis by PILRα.	PILRB PILRA	3.30e-05	3	116	2	25710489
Pubmed	N1-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism.	PPARD TRMT6	3.30e-05	3	116	2	34728628
Pubmed	Nuclear accumulation of symplekin promotes cellular proliferation and dedifferentiation in an ERK1/2-dependent manner.	MAPK3 SYMPK	3.30e-05	3	116	2	28630428
Pubmed	PANP is a novel O-glycosylated PILRα ligand expressed in neural tissues.	PILRB PILRA	3.30e-05	3	116	2	21241660
Pubmed	TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23).	TET2 KMT2A	3.30e-05	3	116	2	12646957
Pubmed	Isobavachalcone exerts anti‑proliferative and pro‑apoptotic effects on human liver cancer cells by targeting the ERKs/RSK2 signaling pathway.	RPS6KA3 MAPK3	3.30e-05	3	116	2	30942462
Pubmed	Nonallelic homologous recombination of the FCGR2/3 locus results in copy number variation and novel chimeric FCGR2 genes with aberrant functional expression.	FCGR2C FCGR2A	3.30e-05	3	116	2	26133275
Pubmed	Protein tyrosine phosphatase epsilon inhibits signaling by mitogen-activated protein kinases.	PTPRE MAPK3	3.30e-05	3	116	2	12754301
Pubmed	The myeloid receptor PILRβ mediates the balance of inflammatory responses through regulation of IL-27 production.	PILRB PILRA	3.30e-05	3	116	2	22479310
Pubmed	LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease.	LRRK2 CLTC	3.30e-05	3	116	2	29735704
Pubmed	BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.	BAP1 BRCA1	3.30e-05	3	116	2	19117993
Pubmed	BRCA1/p220 loss triggers BRCA1-IRIS overexpression via mRNA stabilization in breast cancer cells.	BRCA1 PCBP2	3.30e-05	3	116	2	22431556
Pubmed	Gamma-irradiation-induced DNA damage checkpoint activation involves feedback regulation between extracellular signal-regulated kinase 1/2 and BRCA1.	BRCA1 MAPK3	3.30e-05	3	116	2	18593910
Pubmed	Clathrin promotes centrosome integrity in early mitosis through stabilization of centrosomal ch-TOG.	CLTCL1 CLTC	3.30e-05	3	116	2	22891263
Pubmed	Immunohistochemical Evaluation of BAP1 Expression in Breast Cancer with Known BRCA1 and BRCA2 Mutations and Comparison with Histopathological Features.	BAP1 BRCA1	3.30e-05	3	116	2	35261270
Pubmed	PDK1 promotes the inflammatory progress of fibroblast-like synoviocytes by phosphorylating RSK2.	RPS6KA3 PDPK2P	3.30e-05	3	116	2	28314444
Pubmed	Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis.	FCGR2C FCGR2A	3.30e-05	3	116	2	17785206
Pubmed	The MAPK1/3 pathway is essential for the deregulation of autophagy observed in G2019S LRRK2 mutant fibroblasts.	LRRK2 MAPK3	3.30e-05	3	116	2	22914360
Pubmed	Polymorphism of FCGR2A, FCGR2C, and FCGR3B Genes in the Pathogenesis of Sarcoidosis.	FCGR2C FCGR2A	3.30e-05	3	116	2	26801149
Pubmed	Functional Fcgamma receptor polymorphisms are associated with human allergy.	FCGR2C FCGR2A	3.30e-05	3	116	2	24586589
Pubmed	Clathrin isoform CHC22, a component of neuromuscular and myotendinous junctions, binds sorting nexin 5 and has increased expression during myogenesis and muscle regeneration.	CLTCL1 CLTC	3.30e-05	3	116	2	15133132
Pubmed	Distinct dysregulation of the small leucine-rich repeat protein family in osteoarthritic acetabular labrum compared to articular cartilage.	ASPN OMD	3.30e-05	3	116	2	25371314
Pubmed	Counter-regulation of the ligand-receptor pair Leda-1/Pianp and Pilrα during the LPS-mediated immune response of murine macrophages.	PILRB PILRA	3.30e-05	3	116	2	26188512
Pubmed	FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell Carcinoma.	FCGR2C FCGR2A	3.30e-05	3	116	2	27742794
Pubmed	BRCA1 and CtIP Are Both Required to Recruit Dna2 at Double-Strand Breaks in Homologous Recombination.	BRCA1 DNA2	3.30e-05	3	116	2	25909997
Pubmed	Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy.	LRRK2 C1orf141 CDH18	5.32e-05	22	116	3	25642632
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	DIDO1 ARHGAP35 ADCY6 BAP1 MYO3A SIPA1L1 CLTC KMT2A MAPK3 DNMBP SYMPK	5.84e-05	774	116	11	15302935
Pubmed	RSK2 Maintains Adult Estrogen Homeostasis by Inhibiting ERK1/2-Mediated Degradation of Estrogen Receptor Alpha.	RPS6KA3 MAPK3	6.59e-05	4	116	2	32697984
Pubmed	FLRT3 Marks Direction-Selective Retinal Ganglion Cells That Project to the Medial Terminal Nucleus.	FLRT3 FLRT1	6.59e-05	4	116	2	34955746
Pubmed	PPARβ Regulates Liver Regeneration by Modulating Akt and E2f Signaling.	PDPK2P PPARD	6.59e-05	4	116	2	23823620
Pubmed	RhoC in association with TET2/WDR5 regulates cancer stem cells by epigenetically modifying the expression of pluripotency genes.	TET2 KMT2A	6.59e-05	4	116	2	36469134
Pubmed	Oxidized low density lipoprotein induces cyclin A synthesis. Involvement of ERK, JNK and NFkappaB.	CCNA1 MAPK3	6.59e-05	4	116	2	21764057
Pubmed	Pyruvate Kinase and Fcγ Receptor Gene Copy Numbers Associated With Malaria Phenotypes.	FCGR2C FCGR2A	6.59e-05	4	116	2	28605553
Pubmed	Evolutionarily conserved paired immunoglobulin-like receptor α (PILRα) domain mediates its interaction with diverse sialylated ligands.	PILRB PILRA	6.59e-05	4	116	2	22396535
Pubmed	Coffin-Lowry syndrome: a role for RSK2 in mammalian neurogenesis.	RPS6KA3 MAPK3	6.59e-05	4	116	2	20832397
Pubmed	Regulated expression of FLRT genes implies a functional role in the regulation of FGF signalling during mouse development.	FLRT3 FLRT1	6.59e-05	4	116	2	16872596
Pubmed	Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor.	PILRB PILRA	6.59e-05	4	116	2	14970179
Pubmed	Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway.	LRRK2 MAPK3	6.59e-05	4	116	2	20074637
Pubmed	BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site.	BRCA1 CCNA1	6.59e-05	4	116	2	10373534
Pubmed	Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.	KMT2A SYMPK	6.59e-05	4	116	2	23994619
Pubmed	ERK1/2 regulates ANG II-dependent cell proliferation via cytoplasmic activation of RSK2 and nuclear activation of elk1.	RPS6KA3 MAPK3	6.59e-05	4	116	2	16723511
Pubmed	HIP1 functions in clathrin-mediated endocytosis through binding to clathrin and adaptor protein 2.	CLTCL1 CLTC	6.59e-05	4	116	2	11517213
Pubmed	Phosphoinositide-dependent kinase 1 regulates leukemia stem cell maintenance in MLL-AF9-induced murine acute myeloid leukemia.	PDPK2P KMT2A	6.59e-05	4	116	2	25769952
Pubmed	Structural Basis of Teneurin-Latrophilin Interaction in Repulsive Guidance of Migrating Neurons.	FLRT3 FLRT1	6.59e-05	4	116	2	31928845
Pubmed	Expression pattern of the Rsk2, Rsk4 and Pdk1 genes during murine embryogenesis.	RPS6KA3 PDPK2P	6.59e-05	4	116	2	12711546
Pubmed	OTUB1 modulates c-IAP1 stability to regulate signalling pathways.	UBR5 TAB1 WDR1	6.95e-05	24	116	3	23524849
Pubmed	Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic.	CLTCL1 CLTC	1.10e-04	5	116	2	10436022
Pubmed	Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B.	FCGR2C FCGR2A	1.10e-04	5	116	2	19309690
Pubmed	FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells.	PILRB PILRA	1.10e-04	5	116	2	10903717
Pubmed	The PDK1-Rsk Signaling Pathway Controls Langerhans Cell Proliferation and Patterning.	RPS6KA3 PDPK2P	1.10e-04	5	116	2	26401001
Pubmed	PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling.	PPARD MAPK3	1.10e-04	5	116	2	24213576
Pubmed	Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo.	RPS6KA3 MAPK3	1.10e-04	5	116	2	9915826
Pubmed	Epidermal growth factor receptor (EGFR)-mediated positive feedback of protein-tyrosine phosphatase epsilon (PTPepsilon) on ERK1/2 and AKT protein pathways is required for survival of human breast cancer cells.	PTPRE MAPK3	1.10e-04	5	116	2	22117074
Pubmed	SNPs of Fc-gamma receptor genes and chronic periodontitis.	FCGR2C FCGR2A	1.10e-04	5	116	2	20439936
Pubmed	Mapping of a cadherin gene cluster to a region of chromosome 5 subject to frequent allelic loss in carcinoma.	CDH4 CDH18	1.10e-04	5	116	2	10191097
Pubmed	Copy number, linkage disequilibrium and disease association in the FCGR locus.	FCGR2C FCGR2A	1.10e-04	5	116	2	20508037
Pubmed	Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian families with high risk of breast cancer.	BAP1 BRCA1	1.10e-04	5	116	2	19197335
Pubmed	Comparative analysis of the paired immunoglobulin-like receptor (PILR) locus in six mammalian genomes: duplication, conversion, and the birth of new genes.	PILRB PILRA	1.10e-04	5	116	2	16926269
Pubmed	TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes.	BRCA1 UBR5	1.10e-04	5	116	2	22884692
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	CLTCL1 PLXND1 UBR5 SIPA1L1 CLTC PCBP2	1.43e-04	235	116	6	30258100
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MCMBP MIS18BP1 SORBS1 FAM111B UBR5 CLTC CSTB DNMBP PCBP2	1.63e-04	588	116	9	38580884
Pubmed	Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.	RPS6KA3 MAPK3	1.64e-04	6	116	2	12832467
Pubmed	Development of a screening set for new (CAG/CTG)n dynamic mutations.	PTPRE HMGXB3	1.64e-04	6	116	2	8786123
Pubmed	FancJ (Brip1) loss-of-function allele results in spermatogonial cell depletion during embryogenesis and altered processing of crossover sites during meiotic prophase I in mice.	BRCA1 SYCP1	1.64e-04	6	116	2	26490168
Pubmed	Cytokine-induced iNOS and ERK1/2 inhibit adenylyl cyclase type 5/6 activity and stimulate phosphodiesterase 4D5 activity in intestinal longitudinal smooth muscle.	ADCY6 MAPK3	1.64e-04	6	116	2	24944202
Pubmed	The MAP kinase ERK5 binds to and phosphorylates p90 RSK.	RPS6KA3 MAPK3	1.64e-04	6	116	2	16626623
Pubmed	Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases.	RPS6KA3 MAPK3	1.64e-04	6	116	2	8939914
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	DNAH10 RPS6KA3 PLXND1 LRP1B BAP1 DNASE2B PTPRE GBGT1 KMT2A MAPK3	1.73e-04	730	116	10	34857952
Pubmed	Potential protein partners for the N-terminal domain of human topoisomerase I revealed by phage display.	U2AF2 KMT2A SYMPK	2.01e-04	34	116	3	12549820
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	DIDO1 BRCA1 UBR5 CLTC CSTB PCBP2 SYMPK	2.03e-04	357	116	7	37059091
Pubmed	BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation.	BRCA1 MAPK3	2.29e-04	7	116	2	15735702
ToppCell	COPD-Myeloid-Macrophage\|World / Disease state, Lineage and Cell class	TET2 MIS18BP1 LRRK2 CH25H PPARD NHSL1 FCGR2A SIPA1L1 DNMBP	2.03e-09	194	115	9	7d682408e9a6239a4e47befc9376e760cc3d133a
ToppCell	Control-Myeloid-ncMonocyte\|World / Disease state, Lineage and Cell class	TET2 PILRA LRRK2 PTPRE SIPA1L1 DNMBP FAM20A	7.61e-07	195	115	7	b4444b67a709e82b8e2ee510924c3152cb88b051
ToppCell	COVID-19-Myeloid-Monocytes\|COVID-19 / group, cell type (main and fine annotations)	TET2 PILRA LRRK2 LCP1 IFNGR2 FCGR2A SIPA1L1	7.88e-07	196	115	7	04d710267658ea5601ae2cfb4ed5acb8a29bd8a1
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TET2 FOXN3 PPARD LCP1 PTPRE FCGR2A SIPA1L1	8.15e-07	197	115	7	1eb9ff8467118b943b5d443cb996168e1e1206b5
ToppCell	LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TSNAXIP1 DNAH10 ANKMY1 AK9 DNAH7 C1orf141 CCNA1	8.72e-07	199	115	7	15f7814b7074170eee7ccacaa670b1d128fc68bb
ToppCell	Sigmoid-T_cell-cycling_gd_T\|T_cell / Region, Cell class and subclass	SPATA20 STIL BRCA1 ZFYVE26 OVCA2 DNA2 PRDM15	9.02e-07	200	115	7	4e489ecf472857357d45e9f6c7a812aa48b72ebf
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MIS18BP1 STIL FAM111B MYO3A BRCA1 DNA2	4.81e-06	167	115	6	50c29ea660bf07b890e4ac1a1985d0761d863dee
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PILRA PTPRE SMG9 TAB1 DNA2 DNMBP	4.98e-06	168	115	6	c3d2d573f21350a4a674faff30b06ff644d00ac3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ASPN STIL OMD FAM111B BRCA1 DNA2	5.15e-06	169	115	6	e7514956b2e4298222ec443f98b2f5289451786e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EEF1AKMT4-ECE2 OMD FAM111B MYO3A BRCA1 DNA2	5.15e-06	169	115	6	121768fc51fc3441ec725346a1bbe29e21d05971
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TET2 LCP1 BAP1 IFNGR2 PTPRE FCGR2A	7.88e-06	182	115	6	dc32f8f6a3b13918eb8e93c018f5823d86344080
ToppCell	COPD-Myeloid-cMonocyte\|World / Disease state, Lineage and Cell class	TET2 LRRK2 PPARD PTPRE SIPA1L1 DNMBP	8.38e-06	184	115	6	ceec41ed5636032aaf7716d1203816ea58bd39bd
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	COL15A1 APCDD1 CHP2 GBGT1 DNMBP	8.63e-06	107	115	5	d446ffbe93cd49669f1cf91411aae07cc15d9e2a
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	COL15A1 APCDD1 CHP2 GBGT1 DNMBP	8.63e-06	107	115	5	5c9e745d0b08a4aa1f3a93f9cc094fac57061a30
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC2\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PILRA LRRK2 LCP1 FCGR2C IL22RA2 PTPRE	8.92e-06	186	115	6	69b107ad88b07e9aeef09d4e4dac99b0cb6b467e
ToppCell	Control-Myeloid-cMonocyte\|Myeloid / Disease state, Lineage and Cell class	TET2 LRRK2 PTPRE SIPA1L1 DNMBP FAM20A	9.48e-06	188	115	6	47126c371a242c937499fd278a74a882df8f759c
ToppCell	COPD-Myeloid-cMonocyte\|COPD / Disease state, Lineage and Cell class	TET2 LRRK2 PPARD PTPRE SIPA1L1 DNMBP	9.77e-06	189	115	6	d29f3a0bd23e6eb46389e6eb7ef21851c7b57545
ToppCell	IPF-Myeloid-cMonocyte\|IPF / Disease state, Lineage and Cell class	TET2 LRRK2 PPARD PTPRE SIPA1L1 DNMBP	1.01e-05	190	115	6	a099f51f2b7618b6712af38eedd5ee64d8663a4a
ToppCell	COPD-Myeloid-cDC2\|World / Disease state, Lineage and Cell class	TET2 FOXN3 PPARD NHSL1 SIPA1L1 DNMBP	1.04e-05	191	115	6	4e4887175200a57e1b041f2f131e3df774df3509
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PILRA LRRK2 LCP1 FCGR2C PTPRE FAM20A	1.07e-05	192	115	6	62eac1b8aed4fb924946b58c0237313f697a0136
ToppCell	COPD-Myeloid-ncMonocyte\|COPD / Disease state, Lineage and Cell class	TET2 PILRA LRRK2 PTPRE SIPA1L1 DNMBP	1.10e-05	193	115	6	936ca95995599356b794fba32bfd82d8de339365
ToppCell	RA-08._Macrophage\|World / Chamber and Cluster_Paper	PPARD LCP1 PTPRE FCGR2A SIPA1L1 FAM20A	1.10e-05	193	115	6	5fd22db1825d105709fcc0aa4955c99a117e3c82
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MIS18BP1 PILRB RTTN STIL FAM111B BRCA1	1.13e-05	194	115	6	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TET2 FOXN3 PPARD PTPRE FCGR2A SIPA1L1	1.17e-05	195	115	6	62dc745e1aa3e2e58afa16c7bb2cf9b03d4e8105
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MIS18BP1 RTTN OMD FAM111B BRCA1 DNA2	1.20e-05	196	115	6	df366d76ea55f49e349d622effa57c1535df8400
ToppCell	BL-critical-LOC-Myeloid\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PILRA LRRK2 LCP1 IFNGR2 PTPRE FCGR2A	1.24e-05	197	115	6	932a7fae4979b561688e6222505df0f4e510ab11
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TET2 FOXN3 LCP1 PTPRE FCGR2A SIPA1L1	1.24e-05	197	115	6	8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5
ToppCell	BL\|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NRDC PILRA LRRK2 LCP1 PTPRE FCGR2A	1.24e-05	197	115	6	1acf0191fa0a25cd20bfd9ea7bf727a1555986a1
ToppCell	LPS_only-Hematopoietic_Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages\|LPS_only / Treatment groups by lineage, cell group, cell type	PILRA LCP1 FCGR2C PTPRE CSTB WDR1	1.27e-05	198	115	6	2985c80e656e483866c696fa08c38af90311cd66
ToppCell	critical-Myeloid\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PILRA LRRK2 LCP1 IFNGR2 PTPRE FCGR2A	1.27e-05	198	115	6	a5807517f8ca93b77f49f5787fd9036178b8fc2a
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PILRA LRRK2 LCP1 IFNGR2 FCGR2C PTPRE	1.27e-05	198	115	6	e76061e66f6d60f5735962aa7777dda8958caed9
ToppCell	LPS_only-Hematopoietic_Myeloid-Monocytes,_Macrophages\|LPS_only / Treatment groups by lineage, cell group, cell type	PILRA LCP1 FCGR2C PTPRE CSTB WDR1	1.27e-05	198	115	6	5d48539999d7a17f4165f612bf68be26c085e501
ToppCell	NS-critical-d_0-4-Myeloid\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PILRA LRRK2 LCP1 IFNGR2 PTPRE FCGR2A	1.27e-05	198	115	6	72d51284d267f102c26f0ae8279ee9e11e69c7e3
ToppCell	COPD-Myeloid-Macrophage\|Myeloid / Disease state, Lineage and Cell class	TET2 FOXN3 NHSL1 SIPA1L1 DNMBP FAM20A	1.31e-05	199	115	6	1cf1b2d6debf9e3389f1829dcaa2857e9533a080
ToppCell	COPD-Myeloid-Macrophage\|COPD / Disease state, Lineage and Cell class	TET2 PPARD NHSL1 FCGR2A SIPA1L1 DNMBP	1.31e-05	199	115	6	4b9c53fb4f44190d2f6ad4d52b13be01ebe4955e
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CH25H PPARD TRMT6 FCGR2A SIPA1L1 DNMBP	1.31e-05	199	115	6	951c2ea5af4756832c2adcec3ee70a7e36331a4e
ToppCell	10x5'-bone_marrow-Myeloid_Monocytic\|bone_marrow / Manually curated celltypes from each tissue	PILRA LRRK2 IFNGR2 PTPRE FCGR2A FAM20A	1.31e-05	199	115	6	62b0861faf173eead75678aad10d396cd0d80c2c
ToppCell	10x5'-bone_marrow-Myeloid_Monocytic-Classical_monocytes\|bone_marrow / Manually curated celltypes from each tissue	PILRA LRRK2 IFNGR2 PTPRE FCGR2A FAM20A	1.31e-05	199	115	6	2c747e9265594e12d46bd8c8de75c45e83144155
ToppCell	Transverse-B_cell-B_cell_cycling\|B_cell / Region, Cell class and subclass	LRRK2 STIL FAM111B BRCA1 DNA2 DNMBP	1.31e-05	199	115	6	170ae68963d31f3b821b6f0e8f0c039bea0bc981
ToppCell	Transverse-(2)_B_cell-(24)_B_cell_cycling\|Transverse / shred on region, Cell_type, and subtype	LRRK2 STIL FAM111B BRCA1 DNA2 DNMBP	1.35e-05	200	115	6	e3f9736227151f23f0e331eec0a7a15ce464b517
ToppCell	Transverse-B_cell-B_cell_cycling\|Transverse / Region, Cell class and subclass	LRRK2 STIL FAM111B BRCA1 DNA2 DNMBP	1.35e-05	200	115	6	0e270f8019d9f22068ca426d661937262a5cd331
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-myeloid\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PILRA LRRK2 LCP1 IFNGR2 PTPRE FCGR2A	1.35e-05	200	115	6	6da31ce0a70ad5621444d731c082c0db572c20c5
ToppCell	critical-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MCMBP MIS18BP1 PILRB RTTN STIL FAM111B	1.35e-05	200	115	6	f39db4250ce220a3eb58edee3f7fc3671701d46f
ToppCell	mild-Classical_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 PILRA LRRK2 IFNGR2 PTPRE FCGR2A	1.35e-05	200	115	6	c8b80d4e7f70c66cbbdd0665821bcd5db69c7d35
ToppCell	severe-Classical_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PILRA LRRK2 IFNGR2 TRMT6 PTPRE FCGR2A	1.35e-05	200	115	6	f46689940fdea500ce2457eec412dd2c46705819
ToppCell	mild-HLA-DR+_CD83+_Monocyte\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 PILRA LRRK2 IFNGR2 PTPRE FCGR2A	1.35e-05	200	115	6	8a480f487b52938d00b53bf4b18f067353d34419
ToppCell	Sigmoid-(1)_T_cell-(18)_cycling_gd_T\|Sigmoid / shred on region, Cell_type, and subtype	CH25H STIL BRCA1 ZFYVE26 OVCA2 DNA2	1.35e-05	200	115	6	6e367abd1a4b87e20eb9095b8337723163e8bbae
ToppCell	Sepsis-ICU-NoSEP-Myeloid\|ICU-NoSEP / Disease, condition lineage and cell class	PILRA LRRK2 LCP1 IFNGR2 FCGR2A CSTB	1.35e-05	200	115	6	9fc8b8f16421b5d47e9d0e6d70d59208de5e5290
ToppCell	Sigmoid-T_cell-cycling_gd_T\|Sigmoid / Region, Cell class and subclass	CH25H STIL BRCA1 ZFYVE26 OVCA2 DNA2	1.35e-05	200	115	6	9769185abae084ffac36420c749625e679b70ca8
ToppCell	Biopsy_Other_PF-Immune-Monocytes\|Biopsy_Other_PF / Sample group, Lineage and Cell type	TET2 PILRA LRRK2 LCP1 PTPRE SIPA1L1	1.35e-05	200	115	6	83bca55d48aae8885deb83e15b2684910e4c3358
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	COL15A1 APCDD1 OMD CHP2 GBGT1	2.57e-05	134	115	5	b959899c89d3a0363a3cd2309155280e0fe5ba88
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NDST4 LRP1B MYO3A CDH4 CDH18	4.13e-05	148	115	5	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TSNAXIP1 DNAH10 ANKMY1 AK9 CCNA1	4.54e-05	151	115	5	e335dad89e0a44cdd302b9653154ba5d1ee5fe1a
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TSNAXIP1 DNAH10 ANKMY1 AK9 CCNA1	4.54e-05	151	115	5	633ed52dd3b4cf1e87432cf0a1ca187d7b204e83
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	COL15A1 APCDD1 OMD CHP2 GBGT1	5.81e-05	159	115	5	92049a8d8fc9997d8d0d76500c72596a9b2394e0
ToppCell	Myeloid\|World / shred on cell class and cell subclass (v4)	PILRA LCP1 PTPRE GVINP1 CSTB	6.16e-05	161	115	5	aee407d3739dba2d5216dcdb1579e7e4f483123d
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC1\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MIS18BP1 LRRK2 LCP1 DENND1B PTPRE	6.34e-05	162	115	5	448602d5ff8b5be9614c63540a4d0fe6bdaf23b4
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CH25H STIL BRCA1 NINJ2 MAPK3	6.53e-05	163	115	5	3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STIL FAM111B MYO3A BRCA1 DNA2	6.92e-05	165	115	5	88681101d7cf60b99b8ace5d8c0944323b937306
ToppCell	facs-Spleen-nan-18m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOBP CH25H STIL DOCK7 DNA2	7.12e-05	166	115	5	8d535fab019356894b4dad3fbdbc4d2ad3e16082
ToppCell	facs-Spleen-nan-18m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOBP CH25H STIL DOCK7 DNA2	7.12e-05	166	115	5	f56b1c0d6cb5353a16a2598bda905287f16d2c39
ToppCell	facs-Spleen-nan-18m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOBP CH25H STIL DOCK7 DNA2	7.12e-05	166	115	5	a5074c96c6561273029aceb93402a7e038140f50
ToppCell	343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	STIL FAM111B MYO3A ASB4 DNA2	7.75e-05	169	115	5	a949f547b53126a208819bade74a1ac9b2a36ea7
ToppCell	343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|343B / Donor, Lineage, Cell class and subclass (all cells)	STIL FAM111B MYO3A ASB4 DNA2	7.75e-05	169	115	5	195d5cd60d646ac6d40a3321b2f739917e7aef14
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-Monocytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PILRA LCP1 FCGR2C PTPRE FAM20A	7.97e-05	170	115	5	1c3c03821c90d41de92fef3278f71093a7fd709c
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSNAXIP1 DNAH10 DNAH7 KLHL38 MYO3A	8.65e-05	173	115	5	c3762655caa79ac4879876f470d32578a3c93b01
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OMD SPPL2B NHSL1 SLC12A4 DENND2C	9.38e-05	176	115	5	3766e0533b103ec92ac75eba3df02e287efc53fa
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OMD SPPL2B NHSL1 SLC12A4 DENND2C	9.38e-05	176	115	5	aa1bada2175d8370fc71939a607407155259d195
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MIS18BP1 PTPDC1 CEP70 ZFYVE26 TAB1	9.38e-05	176	115	5	90f8bb11f339f67f08692a0c33dd420f5cda2861
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CH25H PPARD BRCA1 ZFYVE26 FLRT1	9.63e-05	177	115	5	1d5a071157c755f3a27a5c3143015da04ee0b0dc
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSNAXIP1 DNAH10 AK9 DNAH7 SYT14	1.02e-04	179	115	5	5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	STIL FAM111B MYO3A BRCA1 DNA2	1.02e-04	179	115	5	88d44b04eb5c079531db663ed98ddb20b60feb9a
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2\|TCGA-Skin / Sample_Type by Project: Shred V9	C5orf22 NHSL1 SYT14 CLTC DOCK7	1.07e-04	181	115	5	9d5b331cabc5524f0a9fd8b571e87be4c447c7d4
ToppCell	368C-Epithelial_cells-Epithelial-F_(Ciliated)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TSNAXIP1 DNAH10 DNAH7 C1orf141 CCNA1	1.10e-04	182	115	5	975f6275777fc578eba528e50f69891c66ec44ad
ToppCell	368C-Epithelial_cells-Epithelial-F_(Ciliated)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TSNAXIP1 DNAH10 DNAH7 C1orf141 CCNA1	1.10e-04	182	115	5	f8c28fa76751062c4cfba0db8af1b377f947f739
ToppCell	wk_20-22-Epithelial-PNS-intermediate_Schwann\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	COL15A1 SORBS1 PPARD ADCY6 FLRT3	1.16e-04	184	115	5	4e3ba64692868563a579902aa9c6f88cab5bce26
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	MIS18BP1 STIL FAM111B BRCA1 DNA2	1.19e-04	185	115	5	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MIS18BP1 STIL FAM111B MYO3A BRCA1	1.19e-04	185	115	5	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PILRA LRRK2 IFNGR2 PTPRE FCGR2A	1.22e-04	186	115	5	05c40bac5c0ade8b67b7c2112739466e02dbf22b
ToppCell	LPS-antiTNF-Myeloid\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PILRA LCP1 IFNGR2 PTPRE FCGR2A	1.22e-04	186	115	5	839c6da5244f469461b2e5563e36162b2911cd01
ToppCell	5'-Adult-LymphNode-Hematopoietic-Myeloid-Macrophages\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PILRA FCGR2C DNASE2B PTPRE GBGT1	1.25e-04	187	115	5	00930e407beaa337f72533a69f32d150faad8b9a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	STIL FAM111B MYO3A BRCA1 DNA2	1.25e-04	187	115	5	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	COPD-Myeloid-cMonocyte\|Myeloid / Disease state, Lineage and Cell class	TET2 LRRK2 PTPRE SIPA1L1 DNMBP	1.31e-04	189	115	5	6294691231c7d38707323cf31578a107d3b2c622
ToppCell	IPF-Myeloid-ncMonocyte\|Myeloid / Disease state, Lineage and Cell class	PILRA LRRK2 STRADA SIPA1L1 DNMBP	1.31e-04	189	115	5	5c22d2d935f7bb270260b8bc6be67b565ec401bf
ToppCell	IPF-Myeloid-cMonocyte\|Myeloid / Disease state, Lineage and Cell class	TET2 LRRK2 PTPRE SIPA1L1 DNMBP	1.31e-04	189	115	5	ad7bb3a7de8e48c145e4382f90d30bb2159c2b76
ToppCell	COPD-Myeloid-ncMonocyte\|World / Disease state, Lineage and Cell class	TET2 PILRA LRRK2 SIPA1L1 DNMBP	1.34e-04	190	115	5	aece860b5609ad5a8fc920d685f0d0ec71bf9018
ToppCell	COPD-Myeloid-ncMonocyte\|Myeloid / Disease state, Lineage and Cell class	LRRK2 PTPRE STRADA SIPA1L1 DNMBP	1.34e-04	190	115	5	ed978cd5d9da87b49878a330e362762c487f849f
ToppCell	PBMC-Severe-cDC_12\|Severe / Compartment, Disease Groups and Clusters	MCMBP FAM111B BRCA1 CCNA1 DNA2	1.34e-04	190	115	5	84ee185939bdefb10705b621a70da27701eadcee
ToppCell	IPF-Myeloid-cMonocyte\|World / Disease state, Lineage and Cell class	TET2 LRRK2 PTPRE SIPA1L1 DNMBP	1.34e-04	190	115	5	ffa890138394f579fee53fcfac6c121bf86adc26
ToppCell	IPF-Myeloid-ncMonocyte\|World / Disease state, Lineage and Cell class	PILRA LRRK2 STRADA SIPA1L1 DNMBP	1.34e-04	190	115	5	f9c2a13c7f6460e3b348581be855b7281c8f70b5
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RTTN STIL FAM111B BRCA1 DNA2	1.34e-04	190	115	5	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	Control-Myeloid-cDC2\|Control / Disease state, Lineage and Cell class	TET2 FOXN3 PPARD SIPA1L1 SEL1L3	1.34e-04	190	115	5	4e481e42353d47af7991744000403af2873f6a41
ToppCell	PSB-critical-LOC-Myeloid-Neutrophil\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PILRA LRRK2 LCP1 PTPRE FCGR2A	1.41e-04	192	115	5	8dbdaa6a81767a866fb856f99ae35f9ee8064106
ToppCell	kidney_cells-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PILRA CH25H LCP1 PTPRE FCGR2A	1.41e-04	192	115	5	ae7513fde6e33a1908c2777cdb1d1e4ead1bcb2f
ToppCell	NS-moderate-d_16-33-Myeloid-Neutrophil\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PILRA LRRK2 LCP1 PTPRE FCGR2A	1.41e-04	192	115	5	545c3990cbe3c04bfd95a0ab7499d2c4af509be1
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Myeloid-cDC2\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PILRA LRRK2 FCGR2C IL22RA2 PTPRE	1.41e-04	192	115	5	90274b85f3d612b6a6d435860cd6d049ddeb1d96
ToppCell	IPF-Myeloid-ncMonocyte\|IPF / Disease state, Lineage and Cell class	PILRA LRRK2 STRADA SIPA1L1 DNMBP	1.41e-04	192	115	5	e9fb8c57d8094f70fb492909b2bec40aa5f2e5b8
ToppCell	Control-Myeloid-cMonocyte\|Control / Disease state, Lineage and Cell class	TET2 PTPRE SIPA1L1 DNMBP FAM20A	1.41e-04	192	115	5	ad04c9c4bdebf94615cee1904ca48197e62c923b
ToppCell	(3)_Macrophage_MARCOpos\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	PILRA LCP1 DNASE2B FCGR2A CSTB	1.41e-04	192	115	5	b1e2175bd4c02106e52d8f491eea1329ac327ae9
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MIS18BP1 LRRK2 PLXND1 PTPRE FCGR2A	1.44e-04	193	115	5	1db487e5f81849740d57cc3e2b5739e8f7581efb
Drug	Miniglucagon	CLTCL1 NRDC CLTC MAPK3	2.53e-06	20	112	4	CID003080901
Drug	Epirizole [18694-40-1]; Up 200; 17uM; PC3; HT_HG-U133A	SOBP SORBS1 FOXN3 PLXND1 ARHGAP35 DNAH7 ADCY6 LRRN3	6.01e-06	197	112	8	7292_UP
Drug	Alfaxalone [23930-19-0]; Down 200; 12uM; MCF7; HT_HG-U133A	ANKMY1 ARHGAP35 OMD ADCY6 BAP1 SIPA1L1 TAB1 SYMPK	6.23e-06	198	112	8	5451_DN
Drug	4P-PDOT	CLTCL1 CLTC MAPK3	9.53e-06	9	112	3	CID003976006
Drug	geldanamycin	TET2 MIS18BP1 C5orf22 RTTN FAM111B ATP11B KMT2A MAPK3 PCBP2 CDH4	1.52e-05	371	112	10	ctd:C001277
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	TET2 LRRK2 LRP1B BAP1 FAM111B MYO3A	2.34e-05	148	113	6	C0279702
Disease	Sarcomatoid Renal Cell Carcinoma	TET2 LRRK2 LRP1B BAP1 FAM111B	1.37e-04	128	113	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	TET2 LRRK2 LRP1B BAP1 FAM111B	1.37e-04	128	113	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	TET2 LRRK2 LRP1B BAP1 FAM111B	1.37e-04	128	113	5	C1266044
Disease	Papillary Renal Cell Carcinoma	TET2 LRRK2 LRP1B BAP1 FAM111B	1.37e-04	128	113	5	C1306837
Disease	Renal Cell Carcinoma	TET2 LRRK2 LRP1B BAP1 FAM111B	1.37e-04	128	113	5	C0007134
Disease	mean platelet volume	TET2 NRDC RTTN LRRK2 ANKMY1 SORBS1 PLXND1 STIL LCP1 DENND2C DOCK7 N4BP2L2 NINJ2	1.47e-04	1020	113	13	EFO_0004584
Disease	malaria (implicated_via_orthology)	FCGR2C FCGR2A	5.14e-04	9	113	2	DOID:12365 (implicated_via_orthology)
Disease	Motor retardation	RPS6KA3 SYT14	5.14e-04	9	113	2	C0424230
Disease	oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement	LCP1 DOCK7	6.41e-04	10	113	2	EFO_0800333
Disease	triglyceride measurement, intermediate density lipoprotein measurement	TSNAXIP1 DNAH10 LCP1 DOCK7	8.91e-04	111	113	4	EFO_0004530, EFO_0008595
Disease	Clear Cell Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C0431121
Disease	Intraventricular Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C1334271
Disease	Benign Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C0281784
Disease	Intraorbital Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C1334261
Disease	Olfactory Groove Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C1335107
Disease	Angioblastic Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C1527197
Disease	Meningiomas, Multiple	BAP1 CSTB	9.36e-04	12	113	2	C0205834
Disease	Xanthomatous Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C0457190
Disease	Angiomatous Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C0334608
Disease	Psammomatous Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C0334607
Disease	Fibrous Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C0334606
Disease	Meningothelial meningioma	BAP1 CSTB	9.36e-04	12	113	2	C0334605
Disease	Hemangioblastic Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C0334609
Disease	Transitional Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C0334611
Disease	Hemangiopericytic Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C0334610
Disease	Spinal Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C0347515
Disease	Intracranial Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C0349604
Disease	Papillary Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C3163622
Disease	Malignant Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C0259785
Disease	Sphenoid Wing Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C1565951
Disease	Posterior Fossa Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C1565950
Disease	Parasagittal Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C0751304
Disease	Cerebral Convexity Meningioma	BAP1 CSTB	9.36e-04	12	113	2	C0751303
Disease	Microcystic meningioma	BAP1 CSTB	9.36e-04	12	113	2	C1384408
Disease	Secretory meningioma	BAP1 CSTB	9.36e-04	12	113	2	C1384406
Disease	ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis	LRRK2 C1orf141 IFNGR2 DENND1B FCGR2A MAPK3	9.80e-04	295	113	6	EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268
Disease	triglycerides in medium VLDL measurement	DNAH10 LCP1 DOCK7	1.24e-03	55	113	3	EFO_0022155
Disease	triglycerides in large VLDL measurement	DNAH10 LCP1 DOCK7	1.31e-03	56	113	3	EFO_0022178
Disease	myelodysplastic syndrome (implicated_via_orthology)	TET2 BAP1	1.48e-03	15	113	2	DOID:0050908 (implicated_via_orthology)
Disease	nasopharynx carcinoma (is_implicated_in)	TET2 BRCA1	1.48e-03	15	113	2	DOID:9261 (is_implicated_in)
Disease	triglycerides in small VLDL measurement	DNAH10 LCP1 DOCK7	1.67e-03	61	113	3	EFO_0022145
Disease	free cholesterol in very large VLDL measurement	DNAH10 LCP1 DOCK7	1.67e-03	61	113	3	EFO_0022274
Disease	phospholipids in large VLDL measurement	DNAH10 LCP1 DOCK7	1.75e-03	62	113	3	EFO_0022169
Disease	triglycerides to total lipids in very large HDL percentage	LCP1 DOCK7 FLRT1	1.75e-03	62	113	3	EFO_0022339
Disease	total lipids in very large VLDL measurement	DNAH10 LCP1 DOCK7	1.75e-03	62	113	3	EFO_0022313
Disease	phospholipids in very large VLDL measurement	DNAH10 LCP1 DOCK7	1.75e-03	62	113	3	EFO_0022299
Disease	low affinity immunoglobulin gamma Fc region receptor II-a measurement	FCGR2C FCGR2A	1.90e-03	17	113	2	EFO_0021969
Disease	non-Hodgkin lymphoma (is_implicated_in)	FCGR2A KMT2A	1.90e-03	17	113	2	DOID:0060060 (is_implicated_in)
Disease	a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement	GBGT1 PRDM15	1.90e-03	17	113	2	EFO_0008011
Disease	rheumatoid arthritis, COVID-19	IFNGR2 COG6 GBGT1	1.92e-03	64	113	3	EFO_0000685, MONDO_0100096
Disease	cholesterol in large VLDL measurement	DNAH10 LCP1 DOCK7	2.01e-03	65	113	3	EFO_0021902
Disease	cholesterol in very large VLDL measurement	DNAH10 LCP1 DOCK7	2.01e-03	65	113	3	EFO_0022230
Disease	ceramide measurement	ANKMY1 CHP2 GBGT1 PRDM15 CDH18	2.15e-03	235	113	5	EFO_0010222
Disease	total lipids in small VLDL	DNAH10 LCP1 DOCK7	2.19e-03	67	113	3	EFO_0022148
Disease	total lipids in large VLDL	DNAH10 LCP1 DOCK7	2.19e-03	67	113	3	EFO_0022175
Disease	triglycerides to phosphoglycerides ratio	DNAH10 LCP1 DOCK7	2.29e-03	68	113	3	EFO_0022327
Disease	free cholesterol in large VLDL measurement	DNAH10 LCP1 DOCK7	2.29e-03	68	113	3	EFO_0022265
Disease	body mass index, high density lipoprotein cholesterol measurement	DNAH10 FLRT1	2.38e-03	19	113	2	EFO_0004340, EFO_0004612
Disease	Meningioma	BAP1 CSTB	2.38e-03	19	113	2	C0025286
Disease	triglyceride measurement, body mass index	DNAH10 FLRT1	2.38e-03	19	113	2	EFO_0004340, EFO_0004530
Disease	Prostatic Neoplasms	TET2 COL15A1 NDST4 LRP1B BAP1 BRCA1 KMT2A MAPK3	2.59e-03	616	113	8	C0033578
Disease	Malignant neoplasm of prostate	TET2 COL15A1 NDST4 LRP1B BAP1 BRCA1 KMT2A MAPK3	2.59e-03	616	113	8	C0376358
Disease	brain age measurement	EEF1AKMT4-ECE2 KLHL38	2.64e-03	20	113	2	EFO_0010602
Disease	stomach cancer (is_implicated_in)	TET2 LRP1B BRCA1	2.69e-03	72	113	3	DOID:10534 (is_implicated_in)
Disease	free cholesterol to total lipids in large LDL percentage	LCP1 DOCK7 FLRT1	2.91e-03	74	113	3	EFO_0022280
Disease	Primary microcephaly	RTTN STIL	3.19e-03	22	113	2	C0431350
Disease	body weight loss	FOXN3 CDH4	3.19e-03	22	113	2	EFO_0005245
Disease	Ovarian Serous Adenocarcinoma	LRRK2 MYO3A	3.49e-03	23	113	2	C1335177
Disease	R-warfarin measurement	CYP2R1 NINJ2 ZFYVE26 ZNF528 VWA5B1	3.59e-03	265	113	5	EFO_0803324
Disease	Cancer of Head	BAP1 MAPK3	3.80e-03	24	113	2	C0751177
Disease	Head Neoplasms	BAP1 MAPK3	3.80e-03	24	113	2	C0018675
Disease	Upper Aerodigestive Tract Neoplasms	BAP1 MAPK3	3.80e-03	24	113	2	C0887900

Protein segments in the cluster

Peptide	Gene	Start	Entry
LNRQYLKPDAVLHPA	AGBL5	311	Q8NDL9
PLENENIYPHKRTNF	C1orf141	231	Q5JVX7
NPQHKIEYRHNTLPV	APLF	431	Q8IW19
QLFKPLYSSHPQNEI	CXorf66	211	Q5JRM2
QAYNRRLLHNILPKD	ADCY6	941	O43306
AARIYPPQFHKVIQA	ASB4	316	Q9Y574
PPNPRYSHNVQQLKS	GVINP1	1681	Q7Z2Y8
KNIYLTLPPNDHVNS	FCGR2A	301	P12318
KLYLQDNHINRVPPN	FLRT3	251	Q9NZU0
QSLPHENKPLTLSNY	CSTB	71	P04080
RLPAFLDNHNYAKSP	BAP1	356	Q92560
PPLQQSLDHYLKALQ	CRAT	41	P43155
KPRQSSPQLHNLASY	DNMBP	491	Q6XZF7
YHLFPPRQLNDVKTT	DCPS	116	Q96C86
YLSHNQLSEIPLNLP	ASPN	156	Q9BXN1
FPLHNPIIYTLRNKE	OR4M2B	281	A0A0X1KG70
EKNRYPNILPNDHSR	PTPRE	161	P23469
VLISHRYKQLDLPNP	LRP1B	4161	Q9NZR2
KAPLHNLTYELPTLN	MIS18BP1	211	Q6P0N0
PQYQLNRQDAPHLVK	RPS6KA3	686	P51812
LPPQLLNSPYLHDQK	DDX59	571	Q5T1V6
IYLKVQQELPHLPQS	HMGXB3	56	Q12766
AQEQRTPVAPQYHLK	NHSL1	1101	Q5SYE7
DKNIYLTLPPNDHVN	FCGR2C	306	P31995
FNRYPALHKPENQDI	LCP1	371	P13796
HPRRLTDNYNKILQL	PLXND1	116	Q9Y4D7
KPHNVLLFTLYPNAA	LRRK2	1996	Q5S007
VILHAPNLPYRYQKE	IL22RA2	176	Q969J5
NRPIFPGKHYLDQLN	MAPK3	241	P27361
KLYLSDNHLNSLPPE	LRRC10	56	Q5BKY1
ENLHQQTPPKLTAYL	PDPK2P	321	Q6A1A2
PKAHAVTLPQYLIRQ	PTPDC1	256	A2A3K4
LKLQTLPPVQLAHQY	NDST4	546	Q9H3R1
YAIPQPDLTKLHQLA	PCBP2	236	Q15366
PPSIHKDYVNRLFLN	PILRA	86	Q9UKJ1
ITPNKHGLLQNPYRI	BRCA1	966	P38398
NEYKDPENILHRSPQ	COG6	636	Q9Y2V7
LQAPFYARNHPKALN	EEF1AKMT4-ECE2	696	P0DPD8
KRQELPSNCSLPYHV	DNASE2B	271	Q8WZ79
RNYHRLKEALQPLIN	DOCK7	2096	Q96N67
NSIIHNPRAPVIIYK	CEP70	356	Q8NHQ1
NPELLQHIYQPLNLT	GBGT1	96	Q8N5D6
VNRKPQLPQHFVDAY	CYP2R1	266	Q6VVX0
RQNLIQALKKTPYHP	FOXN3	196	O00409
LHKAYLDIPHRPQQA	CCNA1	426	P78396
QSVHYLLKNLPNPTL	C5orf22	381	Q49AR2
NLLPTPAKSHYLFNL	DNAH7	2166	Q8WXX0
QKYPHTHLVQQANPR	GDF11	351	O95390
YHQQNVPRAKLDQAP	BCL9L	266	Q86UU0
INEAPYFPSNHKLIR	CDH4	501	P55283
NNNRHVKDLYLIPLS	DIDO1	1151	Q9BTC0
RPSSYQPPLQNAKNH	APCDD1	246	Q8J025
LHYPAQSFKPNVAER	ANKMY1	336	Q9P2S6
RLAQLQPSSKRNPHY	DENND2C	461	Q68D51
QPSSKRNPHYQTLER	DENND2C	466	Q68D51
LQQHQGHPPKLLSYR	IGLV10-54	56	A0A075B6I4
PAPQHPKIRLYNAEQ	IFNGR2	31	P38484
VNDNPPRFPQKHYQL	CDH18	261	Q13634
LASKHRQPPEYNPND	KMT2A	3781	Q03164
PLNLPSAHLQKLYLQ	FLRT1	236	Q9NZU1
REQILPPQDLSHYIK	FAM111B	321	Q6SJ93
NPISSANYEKPALHL	COL15A1	1206	P39059
NCYPPLEKLLNHLNS	DNA2	1021	P51530
LNETLRSLYNHPVPK	DENND1B	126	Q6P3S1
IFVQNLENPPLYKNH	DNAH10	551	Q8IVF4
YKIHPDFSPSAQQLL	CH25H	71	O95992
SLNEVPLHYLKPNSF	MCMBP	51	Q9BTE3
HNKLQDIPYNIFNLP	OMD	266	Q99983
DPRSQPINLNHYATK	NINJ2	16	Q9NZG7
NLLSRLVKYPPAVQH	RTTN	66	Q86VV8
LEKENEQRLPYPLHN	AK9	1536	Q5TCS8
VSKLFNHPNIVPYRA	STRADA	121	Q7RTN6
HFKNLAANRPPNTYV	SYT14	441	Q8NB59
HAVAKNYTLLQTIPP	SEL1L3	196	Q68CR1
QANHPDAQYLFPKLL	PPARD	386	Q03181
QHQLPPQYQKILERL	TAB1	141	Q15750
IPSDVKVYNLTHLNP	LRRN3	571	Q9H3W5
PSFLPQALHQQYLLQ	RNF165	96	Q6ZSG1
IHRENLPDPNVQKYI	PRDM15	1041	P57071
KLQALFAHPLYNVPE	FAM20A	91	Q96MK3
HLINNDRKLPPEYNL	SMG9	281	Q9H0W8
PYTPNNKQQLLRKRH	SIPA1L1	691	O43166
APQKTSHLQLQPLYT	NKAIN1	191	Q4KMZ8
INYLDRNNPSKPLHV	WDR1	301	O75083
ALPRQDTVIKHYQRP	PRR12	281	Q9ULL5
KAPNLHLQQSYLPRG	TEX45	386	Q8NA69
HFIPAAAPQRQAYLK	OVCA2	206	Q8WZ82
QPHRSTALQPYIKRA	ARHGAP35	106	Q9NRY4
LVPKNIAFYPSNHER	SLC12A4	826	Q9UP95
NHIKHRYPQAPLLAV	ABHD1	186	Q96SE0
PLVKPYLRSVQNHNN	CLTC	1446	Q00610
PLVKPYLRSVQSHNN	CLTCL1	1446	P53675
PEPLNSRRNKLHYAF	CHP2	106	O43745
NYLSRIPPDIAKLHN	CNOT6L	66	Q96LI5
DPHVLQNKPTLYRDI	ATP11B	936	Q9Y2G3
PLLHQPSDNQKIYQD	STIL	926	Q15468
AYRHPDFPLLEKAQQ	ERVFRD-1	16	P60508
NFPQQHYAKETPRLA	SOBP	201	A7XYQ1
KTLYRNNNPPASHLC	SYCP1	911	Q15431
VPNRLIHEKSPYLLQ	SPATA20	61	Q8TB22
IPNNSLPYFHKRPQA	SPPL2B	281	Q8TCT7
QIHKLNRDTPEENPY	SORBS1	401	Q9BX66
YKLQAPLSEPTLSQH	TMEM214	151	Q6NUQ4
PIRAPQKHVTFYQDL	THOC6	256	Q86W42
NPDLHLPAENKYIAT	NRDC	651	O43847
PPSIHKDYVNRLFLN	PILRB	86	Q9UKJ0
KFALNYLQLLVHPNP	SYMPK	751	Q92797
RNYQVLPDRSHPKLL	TRMT6	431	Q9UJA5
GQSLKIRRPHDYQPL	U2AF2	221	P26368
NKYRNNFDHAPLLPQ	ZNF528	161	Q3MIS6
QQHPFRTAKPQYLEE	TSNAXIP1	36	Q2TAA8
QYFPNNVIPKQDLLH	TET2	866	Q6N021
QQSSNPIPKRDLLYH	ZFYVE26	421	Q68DK2
HPVLEKLRSINNYNP	YTHDF2	386	Q9Y5A9
KYNLNSHPPLNVLEQ	UBR5	31	O95071
RAYSTNQITNHKPLP	VWA5B1	656	Q5TIE3
KLLLHVPPRNSYQDF	KLHL38	271	Q2WGJ6
KPPRYLQNDHLRTVQ	MYO3A	551	Q8NEV4
PLPSLNYHLNIQRFS	N4BP2L2	281	Q92802